Malononitrilamides prevent the generation of oxygen radicals in mononuclear phagocytes and graft rejection in a rat model

Transplantation Proceedings

Volumn 31, Issue 1-2, 1999, Pages 851-853

  Schorlemmer, H U ^a   Bartlett, R R ^a   Kurrle, R ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYANO 3 HYDROXY N [(4 TRIFLUOROMETHYL)PHENYL] 2 HEPTEN 6 YNOIC ACID; 2 CYANO 3 HYDROXY N [4 (TRIFLUOROMETHYL)PHENYL] 6 HEPTYNAMIDE; 2 CYANO N (4 CYANOPHENYL) 3 CYCLOPROPYL 3 HYDROXYPROPENOIC ACID AMIDE; 2 CYANO N (4 CYANOPHENYL) 3 CYCLOPROPYL 3 OXOPROPIONAMIDE; DIHYDROOROTATE DEHYDROGENASE; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; MALONONITRILAMIDE DERIVATIVE; OXYGEN RADICAL; TERIFLUNOMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DOSE CALCULATION; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG MECHANISM; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; MONONUCLEAR PHAGOCYTE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; SKIN ALLOGRAFT; SKIN TRANSPLANTATION;

ACRYLAMIDES; ACUTE DISEASE; ALKYNES; ANIMALS; CHEMILUMINESCENT MEASUREMENTS; FREE RADICALS; GRAFT REJECTION; HEXANOIC ACIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; MACROPHAGES; MONOCYTES; NITRILES; RATS; RATS, INBRED LEW; RATS, INBRED STRAINS; SKIN TRANSPLANTATION;

EID: 0032986385     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01801-6     Document Type: Conference Paper

References (19)

1. Schorlemmer H.U., Bartlett R.R. Inflamm Res. 46:1997;S167.
2. Schorlemmer H.U., Bartlett R.R. Drugs Exp Clin Res. 23:1997;175.
3. Schorlemmer H.U., Kurrle R., Bartlett R.R. Inflamm Res. 46:1997;S165.
4. Schorlemmer H.U., Kurrle R., Bartlett R.R. Drugs Exp Clin Res. 23:1997;167.
5. Hausen B., Boeke K., Berry G.J., et al. Transplantation. 65:1998;209.
6. Schorlemmer H.U., Ruuth E., Kurrle R. Int Immunother. 13:1997;9.
7. Lin Y., Segers C., Waer M. Transplant Proc. 28:1996;3036.
8. Schorlemmer H.U., Kurrle R. Transplantation. 65:1998;195.
9. Schorlemmer H.U., Kurrle R. Int J Tiss Reac. 19:1997;149.
10. Schorlemmer H.U., Kurrle R. Transplant Proc. 28:1996;3037.
11. Czech J., Schwab W., Schorlemmer H.U. Transplantation. 65:1998;115.
12. Kurrle R., Ruuth E., Bartlett R.R., et al. Transplant Proc. 29:1997;1302.
13. Czech J., Schorlemmer H.U., Schwab W. Transplant Proc. 28:1996;3051.
14. Kurrle R., Bartlett R.R., Ruuth E., et al. Transplant Proc. 28:1996;3053.
15. Silva H.T., Slauson S., Shorthouse R., et al. Transplantation. 65:1998;104.
16. Kuo E.A., Hambleton P.T., Kay D.P., et al. J Med Chem. 39:1996;4608.
17. Williamson R.A., Yea C.M., Robson R.A., et al. J Biol Chem. 270:1995;22467.
18. Schorlemmer H.U., Bosslet K., Dickneite G., et al. Behring Inst Mitt. 74:1984;157.
19. Schorlemmer H.U., Schwab W., Ruuth E., et al. Transplant Proc. 28:1996;3048.